New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 17:53:04 Source:styleViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:California congressman urges closer consultation with tribes on offshore wind
Next:Yu Darvish extends scoreless innings streak to 25 in Padres' 9
You may also like
- Philippines blames China for loss of giant clams in disputed shoal and urges environmental inquiry
- Chinese organization to boost recycling of renewable resources
- Atlantic City mayor and wife charged with abusing and assaulting teenage daughter
- Justin Verlander is likely to make his season debut for the Astros this weekend at Washington
- Socialite Jasmine Hartin enjoys beach snuggle with electrician hunk
- China sees nearly 119 mln domestic tourist trips during Qingming holiday
- Audit cites potential legal violations in purchase of $19,000 lectern for Arkansas governor
- NBA attendance: League says 71% of games this season were sellouts
- Company wins court ruling to continue development of Michigan factory serving EV industry